CAR- and TCR-engineered therapies
From biomarker and binder strategy through construct design, gene delivery and functional characterization.
Explore CAR-T developmentEngineered Immune Cell Therapy Discovery and Development
We help research teams translate ambitious ideas in engineered immunity into clear, executable development programs—from discovery and design to translational evaluation and development readiness.
Who We Are
Creative Biolabs is a biotechnology research and development partner specializing in engineered immune cell therapy discovery, engineering, evaluation and development support. We work closely with biotechnology, pharmaceutical and academic teams to address scientific and technical challenges across CAR-T, CAR-NK, TCR-T, TIL and other immune cell modalities, alongside cancer vaccine development, receptor engineering, cell engineering, delivery strategies, functional evaluation and translational readiness.
Our role extends beyond delivering isolated services. We build application-driven, mechanism-aware workflows around the realities of each program—connecting target and binder strategy, receptor and vector design, cell engineering, in vitro and in vivo evaluation, process development and decision-ready reporting from early concept validation through preclinical-stage planning.
Our Expertise
Our multidisciplinary teams connect target biology, receptor design, cell engineering, cellular function, translational evidence and development planning—so every work package contributes to the larger program.
From biomarker and binder strategy through construct design, gene delivery and functional characterization.
Explore CAR-T developmentCAR-NK, CAR-MA, TIL, CIK, CAR-Treg, CAR-B, CAR-monocyte and other cell-based strategies.
Discover CAR-NK capabilitiesAntigen and epitope research, vaccine engineering, characterization and in vivo assessment.
Explore vaccine developmentAllogeneic development, CRISPR editing, mRNA and LNP delivery, logic-gated designs and direct in vivo engineering.
Explore in vivo developmentCustom in vitro assays, relevant models and studies addressing efficacy, specificity, persistence and toxicity.
Explore functional developmentProcess and analytical development plus plasmid, viral vector, IVT RNA, LNP and engineered cell capabilities.
Explore CDMO capabilitiesDevelopment Continuum
Engage us for a focused study or a coordinated program. Each phase can stand alone or connect with adjacent workstreams to keep methods, data and decision criteria aligned.
Targets, biomarkers, antigens, epitopes, binders, TCRs and feasibility strategy.
Construct design, sequence optimization, vectors, delivery and cellular engineering.
In vitro potency and phenotype studies with fit-for-purpose in vivo models.
Mechanistic studies, biomarkers, immune monitoring and safety-oriented evidence.
Process, analytics, manufacturing preparation and support for later development milestones.
Scope, quality level, documentation and regulatory relevance are defined for each project according to its intended use and stage of development.
Technology Platforms
Our platform portfolio gives teams multiple ways to interrogate target biology, engineer cellular function and generate evidence that supports the next decision.
CellRapeutics™ CAR and TCR technologies, CRISPR-edited cells, mRNA engineering, stable packaging cell lines and bispecific strategies.
View engineering platforms →T-Scan, Surfarray™ cell microarrays, Tseeking™ TCR/ligand discovery and display-based approaches for high-throughput interrogation.
Explore discovery technologies →Animal models, organoids, trial-on-chip and immune monitoring for efficacy, persistence, safety and mechanism studies.
Explore translational models →Connected process and analytical development for plasmids, viral vectors, IVT RNA, LNPs and engineered cells.
Explore process development →How We Work
We translate the scientific objective into a transparent work plan, then keep methods, milestones and outputs connected to the evidence your team needs.
We align on the biology, development stage, intended use, constraints and criteria for a meaningful result.
We shape fit-for-purpose work packages with appropriate controls, decision points, deliverables and reporting expectations.
Established platforms and custom methods are selected according to the modality, scientific risk and stage of the program.
Data and technical interpretation are organized to support the next experiment, candidate choice or development path.
Why Creative Biolabs
Building on two decades of biotechnology experience, we support global biopharma, biotechnology and academic teams with flexible, scientifically grounded collaboration.
Coordinate adjacent disciplines through one program view without rebuilding context across disconnected vendors.
Begin with one assay, a focused work package or an integrated plan, then expand when the evidence supports it.
Select technologies according to the target, cell type, construct, delivery route and development stage.
Connect study design, controls, milestones and reporting to the decisions that move a program forward.
Global Collaboration
Creative Biolabs supports biotechnology, pharmaceutical and academic research teams worldwide with responsive scientific communication and flexible program design.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.